InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.40
-0.59 (-4.22%)
Jul 30, 2026, 3:40 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 28.5 billion as of July 29, 2026. Its market cap has decreased by -17.80% in one year.
Market Cap
28.50B
Enterprise Value
22.52B
Revenue
2.87B
Ranking
n/a
PE Ratio
28.35
Stock Price
13.40
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 28.50B, an increase of 132.10%. That is a compound annual growth rate of 14.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 28.50B | 20.31% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 65.64B |
| Biocytogen Pharmaceuticals (Beijing) | 49.57B |
| 3SBio | 43.56B |
| Genscript Biotech | 38.08B |
| Shanghai Junshi Biosciences | 36.80B |
| Shanghai Henlius Biotech | 28.94B |
| Keymed Biosciences | 22.17B |
| Duality Biotherapeutics | 20.00B |